EV Biologics (EV Biologics) Ending Cash Position : $0.00 Mil (As of Dec. 2017)

View and export this data going back to 2015. Start your Free Trial

What is EV Biologics Ending Cash Position?

EV Biologics's Ending Cash Position for the quarter that ended in Dec. 2017 was $0.00 Mil.

EV Biologics's quarterly Ending Cash Position declined from Dec. 2016 ($8.06 Mil) to Jun. 2017 ($0.00 Mil) but then stayed the same from Jun. 2017 ($0.00 Mil) to Dec. 2017 ($0.00 Mil).

EV Biologics's annual Ending Cash Position declined from Jun. 2015 ($16.47 Mil) to Jun. 2016 ($2.74 Mil) and declined from Jun. 2016 ($2.74 Mil) to Jun. 2017 ($1.81 Mil).

EV Biologics Ending Cash Position Historical Data

The historical data trend for EV Biologics's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EV Biologics Ending Cash Position Chart

EV Biologics Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Ending Cash Position

5.79

19.73

16.47

2.74

1.81

EV Biologics Quarterly Data
	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Jun17	Dec17
Ending Cash Position	Get a 7-Day Free Trial												2.74	2.66	8.06	-	-

EV Biologics Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

EV Biologics's Ending Cash Position for the fiscal year that ended in Jun. 2017 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	2.735	+	-0.921
	=	1.81

EV Biologics's Ending Cash Position for the quarter that ended in Dec. 2017 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0	+	0
	=	0.00

EV Biologics Ending Cash Position Related Terms

Thank you for viewing the detailed overview of EV Biologics's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

EV Biologics (EV Biologics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EV Biologics Inc (OTCPK:YECO) » Definitions » Ending Cash Position

Comparable Companies

XCNQ:NIRV ENVB BLCM NLSP BRTX ADTX XKRX:066830 ALLR XMAD:ADL ARTL

Traded in Other Exchanges

N/A

Address

1621 Central Avenue, Cheyenne, WY, USA, 82001

Website

https://www.evbiologics.com

EV Biologics Inc is developing the extraordinary biological properties of extracellular vesicles (EVs) to create the next generation of diagnostic modalities and safe, effective biotherapeutics to improve outcomes of serious clinical conditions, increase natural longevity and transform lives.

Executives

Daniel S Mckinney	director, 10 percent owner, officer: CEO	TWO IFC, 19TH FLOOR, 8 FINANCE STREET, CENTRAL, HONG KONG F4 000000
Michael W Harlan	director	C/O WASTE CONNECTIONS, INC., 610 APPLEWOOD CRESCENT, SUITE 200, VAUGHAN A6 L4K 0C3